Table 3 Evaluation of accuracy of the analytical HPTLC procedure for determination of the investigated drugs
Drug | Conc. (ng/spot) | Amount found (ng/spot) | % Recovery a ± SD |  | |
|---|---|---|---|---|---|
Avanafil | 200 | 196.06 | 98.03 ± 2.07 |  | |
400 | 401.88 | 100.47 ± 2.98 |  | ||
600 | 594.9 | 99.15 ± 0.18 |  | ||
Duloxetine | 200 | 201.62 | 100.81 ± 1.40 |  | |
400 | 405.28 | 101.32 ± 1.24 |  | ||
600 | 608.16 | 101.36 ± 1.52 |  | ||